RxDoctor Payments Data

Todd Robinson, MD

Family Medicine · Cedartown, GANPI 1093870354

Payments from drug & device makers

$4,176in general payments, 2019–2025

Across 296 payments — averaging $14.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$457
  • Astellas Pharma US Inc$365
  • Pfizer$324
  • Novartis$227
  • GSK$194
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$4,156100%
  • Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,176 in reported general payments places this provider in the 80th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$142,133
Medicare patients
366
Services billed
42,715

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide79$114,611
JardianceEmpagliflozin89$75,772
OzempicSemaglutide42$67,877
ProliaDenosumab27$46,154
EliquisApixaban37$37,071
JanuviaSitagliptin Phosphate21$34,202
TrulicityDulaglutide24$33,086
MyrbetriqMirabegron45$28,332
TradjentaLinagliptin25$24,667
FarxigaDapagliflozin Propanediol11$17,019
XareltoRivaroxaban15$13,174
JanumetSitagliptin Phos/Metformin Hcl13$7,160
Breo ElliptaFluticasone/Vilanterol12$5,008
Levothyroxine Sodium380$4,804
Valsartan166$4,596

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$112$147,697103 claims
Boehringer IngelheimJardiance, Tradjenta$30$100,439114 claims
Novo NordiskOzempic$457$67,87742 claims
AmgenProlia$46$46,15427 claims
PfizerEliquis$324$37,07137 claims
Astellas Pharma US IncMyrbetriq$365$28,33245 claims
Johnson & JohnsonXarelto$100$13,17415 claims
GSKBreo Ellipta$194$5,00812 claims
AbbVieSynthroid$1,484$4,09340 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Cedartown

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →